CD4 and non-small cell lung carcinoma: A CD4 helper T-inducer cancer vaccine (UCPVax), previously studied in non-small cell lung cancer (NSCLC), has been investigated in combination with ICI for HPV+ cancers including SCCA in VolATIL [98].